Top 10 Most Read
9th Circuit strikes down felon's firearm conviction
Transactions
Jan. 8, 2002
AMGEN BUYS IMMUNEX IN BIG BIOTECH MARRIAGE
In the largest biotechnology merger in the United States, Amgen Inc. has acquired Immunex Corp. The stock and cash deal, announced Dec. 17, is worth $16 billion.
Thousand Oaks-based Amgen sells drugs for nephrology, cancer, inflammatory disorders and metabolic and neurodegenrenative disorders. Its signature products are EPOGEN, an anti-anemia drug and NEUPOGEN, a drug taken duri...